What You Should Know:
– Lunit, a leading provider of AI-powered cancer diagnostics solutions, has announced a strategic alliance with VIDI Group, the largest private radiology and radiotherapy network in France.
– The partnership will expand…
Continue Reading
What You Should Know:
– Starget Pharma, an innovative startup specializing in precision cancer diagnostics and targeted radiotherapy, has secured $5.1M in funding from Cancer Focus, a fund established in collaboration with the renowned MD…
Continue Reading
Chancellor Rachel Reeves has announced £1.5bn in capital funding for new surgical hubs and scanners to support the delivery of an extra two million NHS appointments a year in England.
Ahead of her budget on…
In multicentric studies, data sharing between institutions might negatively impact patient privacy or data security. An alternative is federated analysis by secure multiparty computation. This pilot study demonstrates an architecture and implementation addressing both…
Continue Reading
Introduction
The radiotherapy market is experiencing significant growth, driven by an increasing incidence of cancer and advancements in technology. According to a recent analysis by Mordor Intelligence, the market is expected to expand substantially from…
Table of Contents
Introduction
Elekta Evo: An Overview
Key Features of the Elekta Evo
Benefits of Adaptive Radiotherapy
Elekta ONE Planning: A Comprehensive Treatment Planning System
Industry Reception and Future Prospects of Elekta Evo
FAQs
Conclusion
Introduction
The recent unveiling of Elekta Evo, an…
What You Should Know:
AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).The acquisition marks a major step forward in AstraZeneca delivering on its ambition to…
Continue Reading
Varian, a Siemens Healthineers company, has obtained FDA clearance for its TrueBeam and Edge radiotherapy systems featuring the innovative HyperSight imaging solution. This advancement aims to enhance treatment accuracy and minimize damage to healthy…
Continue Reading
The UK government has made a multi-million pound investment in potential breakthrough medical devices. As part of a £10 million funding package for boosting access to medical technology, eight innovative tech companies will be supported…
Continue Reading
The Royal Marsden, a renowned cancer center, is pioneering Online Adaptive Radiation Therapy (OART) with RaySearch’s advanced technology. Supported by The Royal Marsden Cancer Charity, the center aims to implement the ARTemis solution, developed…
Continue Reading
